Conclusion
the dossier summarised in one paragraphThe computed 12-month bankruptcy probability of CRYSTAPHARM is 0.1% (very low). The company has been active since 2001 and the Belgian State Gazette contains no insolvency or warning signals. No processed annual-account figures are available; this conclusion rests on registry and State Gazette data only.
Based on State Gazette and CBE data.
Financials
No processed annual-account figures available.
To financials
People & board
1 mandate
1
active director
CLENA CONSULTINGDirector
All directors & mandates Publicationslatest 21-01-2026
11
publications in the State GazetteArticles of association amended — translation of the articles, coordination of the articles and amendment of specific…All publications & acts Network & structure
3
connected companiesSee network & structure
Connections
3 connected companiesParent · 1 subsidiary · 1 location
Control→
Trust signals
3 signalsLong-established
Founded in 2001 — 24 years in business.
No legal incidents
No bankruptcy, reorganisation or interim measure in the Belgisch Staatsblad.
Administratively compliant
No FOD Economie strikeouts (UBO, accounts, address, activity).
Administrative Flags
0 events
No administrative flags
Bankruptcy probability (12 mo)
Checked model v1 · free for everyone0.1%
Very low
0%0,5%1,5%4%10%≥25%
Lower-failure-rate sector
−Long track record
−
Statistical estimate based on public sources — not credit advice nor a finding of fact. How do we compute this?
Company registry (CBE)
Crossroads BankActivities
Accountants en belastingconsulenten69201Activiteiten van (gecertificeerde) (fiscaal) accountants69201
Primary activity highlighted.
Names & trade names
| Legal nameNL | CRYSTAPHARM |
Registered office
Noorderlaan 76
8790 Waregem, Belgium
Official data from the Crossroads Bank for Enterprises (CBE). Available for every registered company.